Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ERSP trims MytoSlim fat burn claims

This article was originally published in The Tan Sheet

Executive Summary

Weight Management Institute discontinues marketing claims that its weight-loss supplement can "increase fat burning enzyme activity up to 10 times normal levels" and help users "lose up to 3 times more body fat" amid an Electronic Retailing Self-Regulation Program inquiry. Brea, Calif.-based WMI substantiated the claim that MytoSlim enables "200% more weight loss than diet and exercise alone," ERSP said June 24. The Council of Better Business Bureaus program made similar recommendations for nearly identical claims for Zylotrim, which contains 7-Keto DHEA, the same active ingredient as MytoSlim (1"The Tan Sheet" March 30, 2009, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103060

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel